Lupus & antiphospholipid syndrome

A case–control study on autoimmune polyendocrine syndromes in patients with systemic lupus erythematosus

Rheumatology (Oxford)Published Case–control study

Authors' conclusion

The prevalence of autoimmune polyendocrine syndrome among SLE patients is significantly higher than in the general population (11% vs 0.005%), confirming the association between autoimmune thyroiditis and SLE. However, autoimmune polyendocrine syndrome-positive patients do not appear to have a more aggressive disease or develop more complications.

Study context

Population
SLE patients (SLICC 2012 and/or EULAR/ACR 2019 criteria) referred to one centre between 2021 and 2023clinical charts analysed
Participants
417 patients
Comparison
SLE with autoimmune polyendocrine syndrome vs SLE without autoimmune polyendocrine syndrome
  • Autoimmune polyendocrine syndrome-positiven = 47
  • Autoimmune polyendocrine syndrome-free SLEn = 185reference
Outcome
Prevalence of autoimmune polyendocrine syndromes in SLE
Methodological detailssingle-centre, randomly enrolled controls
  • Single-centre
  • Randomly enrolled controls

Main finding

As reported in the abstract

Prevalence of autoimmune polyendocrine syndrome

APS-POSITIVE

11%

47 events

Hashimoto thyroiditis
39
Graves' disease
6
Type 1 diabetes mellitus
3
Autoimmune polyendocrine syndrome type 3
45
Autoimmune polyendocrine syndrome type 4
2
Autoimmune polyendocrine syndrome types 1 or 2
0

Further findings

Clinical and serological features

No significant differences between APS-positive and APS-negative patients

Clinical remission at last evaluation

∼80% of both groups in clinical remission; approximately half remained on steroid therapy

SLICC Damage Index (SDI), median

Slightly higher median SDI in APS-positive patients, not associated with increased disease activity

Original publication

A case–control study on autoimmune polyendocrine syndromes in patients with systemic lupus erythematosus. Rheumatology (Oxford). Published 10 June 2025. doi:10.1093/rheumatology/keaf320

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.